Sam Tan is the founder of Bionexus Gene Lab. Bionexus Gene Lab has raised $500M in total funding. Backed by ARC Group International.
Sam Tan is the Chief Executive Officer of BioNexus Gene Lab Corp. The company is an emerging provider of precision oncology diagnostics with expanding operations across Southeast Asia. BioNexus Gene Lab Corp. secured a $500 million equity facility from ARC Group International to support its expansion of precision diagnostics, CDMO operations, and therapeutic commercialization.
Full founder directory · Investor directory · Company funding database · Fundraising library